Zurcher Kantonalbank (Zurich Cantonalbank) Tg Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 31,147 shares of TGTX stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,147

Previous 31,147 -0.0%

Holding current value

$1.05 Million

Previous $728,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$17.21 - $25.28 $57,601 - $84,612	3,347 Added 12.04%	31,147 $728,000
Q2 2024 Jul 29, 2024	SELL	$13.32 - $19.19 $8,351 - $12,032	-627 Reduced 2.21%	27,800 $494,000
Q1 2024 Apr 25, 2024	SELL	$13.02 - $21.3 $69,201 - $113,209	-5,315 Reduced 15.75%	28,427 $432,000
Q4 2023 Jan 30, 2024	BUY	$6.68 - $18.81 $48,964 - $137,877	7,330 Added 27.75%	33,742 $576,000
Q3 2023 Oct 25, 2023	BUY	$8.36 - $26.5 $23,449 - $74,332	2,805 Added 11.88%	26,412 $220,000
Q2 2023 Aug 07, 2023	BUY	$15.48 - $35.0 $19,365 - $43,785	1,251 Added 5.6%	23,607 $586,000
Q4 2022 Feb 01, 2023	BUY	$5.01 - $11.83 $21,527 - $50,833	4,297 Added 23.79%	22,356 $264,000
Q1 2022 Apr 21, 2022	BUY	$7.81 - $20.45 $21,828 - $57,157	2,795 Added 18.31%	18,059 $172,000
Q4 2021 Feb 01, 2022	BUY	$15.2 - $35.51 $65,147 - $152,195	4,286 Added 39.04%	15,264 $290,000
Q1 2021 May 03, 2021	SELL	$41.61 - $54.3 $49,349 - $64,399	-1,186 Reduced 9.75%	10,978 $529,000
Q4 2020 Jan 28, 2021	BUY	$25.27 - $54.9 $23,400 - $50,837	926 Added 8.24%	12,164 $633,000
Q3 2020 Nov 06, 2020	BUY	$18.49 - $27.24 $61,183 - $90,137	3,309 Added 41.73%	11,238 $301,000
Q2 2020 Jul 28, 2020	BUY	$8.9 - $21.84 $16,883 - $41,430	1,897 Added 31.45%	7,929 $154,000
Q1 2020 May 06, 2020	BUY	$7.14 - $15.99 $11,745 - $26,303	1,645 Added 37.5%	6,032 $59,000
Q1 2018 May 03, 2018	BUY	$8.7 - $16.8 $18,548 - $35,817	2,132 Added 94.55%	4,387 $62,000
Q3 2017 Nov 08, 2017	BUY	$10.0 - $12.7 $22,550 - $28,638	2,255	2,255 $27,000

Others Institutions Holding TGTX

# of Institutions

339

Shares Held

88.5M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.88B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Tg Therapeutics, Inc. Transaction History